A revolutionary cancer treatment could transform autoimmune disease
Summary
CAR T cell therapy is a new treatment originally created to fight cancer by changing a patient’s immune cells. Researchers are now testing it for autoimmune diseases like multiple sclerosis, aiming to reset the immune system to stop it from attacking the body.Key Facts
- CAR T therapy modifies T cells to find and destroy harmful cells.
- It was first approved in 2017 to treat certain blood cancers.
- The treatment has helped many cancer patients achieve long-term remission.
- Scientists are now running clinical trials to test CAR T for autoimmune diseases such as multiple sclerosis and lupus.
- Autoimmune diseases often involve B cells that wrongly attack healthy tissue.
- CAR T targets B cells by programming T cells to recognize and kill them.
- The therapy carries risks like severe inflammation and uncertain long-term effects.
- Patient Jan Janisch-Hanzlik received this experimental treatment to manage her multiple sclerosis and hopes it will protect her grandchildren from similar issues.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
